Loomis, Sayles & Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.2M Buy
26,324
+4,636
+21% +$1.8M 0.01% 378
2025
Q1
$9.43M Sell
21,688
-76,690
-78% -$33.4M 0.01% 363
2024
Q4
$36.3M Buy
98,378
+39,893
+68% +$14.7M 0.05% 161
2024
Q3
$30.4M Buy
58,485
+4,844
+9% +$2.52M 0.04% 196
2024
Q2
$29.1M Sell
53,641
-3,330
-6% -$1.8M 0.04% 194
2024
Q1
$29.5M Buy
56,971
+39,362
+224% +$20.4M 0.04% 204
2023
Q4
$8.3M Buy
17,609
+8,798
+100% +$4.15M 0.01% 354
2023
Q3
$3.84M Sell
8,811
-494
-5% -$215K 0.01% 408
2023
Q2
$4.13M Buy
9,305
+480
+5% +$213K 0.01% 406
2023
Q1
$4.06M Buy
8,825
+312
+4% +$143K 0.01% 410
2022
Q4
$4.37M Sell
8,513
-107
-1% -$54.9K 0.01% 381
2022
Q3
$3.92M Sell
8,620
-21,799
-72% -$9.9M 0.01% 378
2022
Q2
$14.7M Sell
30,419
-17,631
-37% -$8.51M 0.03% 300
2022
Q1
$23.6M Sell
48,050
-39,084
-45% -$19.2M 0.03% 266
2021
Q4
$40.4M Sell
87,134
-33,512
-28% -$15.5M 0.05% 198
2021
Q3
$45M Buy
120,646
+7,275
+6% +$2.71M 0.06% 172
2021
Q2
$43.3M Sell
113,371
-18,844
-14% -$7.19M 0.05% 187
2021
Q1
$47.5M Buy
132,215
+95,628
+261% +$34.3M 0.06% 148
2020
Q4
$11.7M Buy
36,587
+32,736
+850% +$10.5M 0.02% 339
2020
Q3
$1.03M Sell
3,851
-93
-2% -$25K ﹤0.01% 443
2020
Q2
$1.04M Buy
3,944
+1,413
+56% +$372K ﹤0.01% 453
2020
Q1
$574K Buy
2,531
+2,108
+498% +$478K ﹤0.01% 489
2019
Q4
$128K Buy
423
+39
+10% +$11.8K ﹤0.01% 555
2019
Q3
$92K Buy
+384
New +$92K ﹤0.01% 558
2019
Q2
Sell
-9,042
Closed -$2.59M 622
2019
Q1
$2.59M Buy
+9,042
New +$2.59M 0.01% 484
2018
Q1
Sell
-127
Closed -$29K 881
2017
Q4
$29K Buy
+127
New +$29K ﹤0.01% 700
2017
Q2
Sell
-53
Closed -$9K 959
2017
Q1
$9K Buy
+53
New +$9K ﹤0.01% 809
2016
Q2
Sell
-42
Closed -$6K 1036
2016
Q1
$6K Sell
42
-34
-45% -$4.86K ﹤0.01% 914
2015
Q4
$11K Hold
76
﹤0.01% 848
2015
Q3
$11K Hold
76
﹤0.01% 897
2015
Q2
$12K Buy
+76
New +$12K ﹤0.01% 792